Published • loading... • Updated
Medpace: Q3 Earnings Snapshot
The clinical development services provider logged $716 million in quarterly revenue and forecast full-year revenue of up to $2.86 billion.
- On Wednesday, Cincinnati-based Medpace Holdings Inc. reported third-quarter profit of $137.5 million, marking a significant financial milestone for the clinical development services provider.
- Revenue for the period reached $716 million, supporting Medpace's operations as a provider of outsourced clinical development services to pharmaceutical and biotech clients.
- Earnings reached $4.84 per share, demonstrating the company's profitability on a per-share basis during the third quarter and exceeding analyst expectations.
- Medpace raised full-year revenue guidance to a range of $2.84 billion to $2.86 billion, signaling confidence in continued growth through the remainder of the fiscal year.
- These results position the Cincinnati firm as a strong performer in outsourced clinical development, with third-quarter execution supporting investor confidence heading into year-end.
Insights by Ground AI
7 Articles
7 Articles
Medpace (NASDAQ:MEDP) Announces Earnings Results, Beats Expectations By $0.40 EPS
Medpace (NASDAQ:MEDP - Get Free Report) released its quarterly earnings data on Wednesday. The company reported $4.84 earnings per share for the quarter, beating the consensus estimate of $4.44 by $0.40. Medpace had a return on equity of 110.15% and a net margin of 17.67%. The business had revenue of $716.00 million for the quarter, compared to analysts' expectations of $714.47 million.
·Sioux Falls, United States
Read Full Article
Medpace Holdings, Inc. Reports Third Quarter 2026 Results
·Crystal River, United States
Read Full ArticleCoverage Details
Total News Sources7
Leaning Left0Leaning Right2Center4Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
